International Journal of Pharmaceutical Investigation logo
Article

Design and development and evaluation of candesartan cilexetil liquid filling formulations

1★, 1★ Corresponding author

  1. 1Department of Pharmaceutics, Bapatla College of Pharmacy, Bapatla, Guntur, Andhra Pradesh, INDIA.

CORRESPONDENCE

Y Deepthi

Department of Pharmaceutics, Bapatla College of Pharmacy, Bapatla, Guntur, Andhra Pradesh, INDIA.

yalavarthi.deepthi@gmail.com

Volume 5, Issue 2 · pp. 81-86 · 2015 · DOI: 10.4103/2230-973X.153382

ABSTRACT

Most of the currently available drugs are having poor water solubility and suffer from low oral bioavailability. One of the most promising approaches to deliver such insoluble drugs is by dissolving it in lipids, liquids or semi-solids to formulate new products.[1] Candesartan meets the requirement of high potency but it is poorly absorbed when administered as tablets. Therefore the prodrug Candesartan cilexitil is developed.[2] Two piece hard gelatin liquid filling capsules are one of the most logical approaches when choosing the best dosage form to deliver these new liquid formulations.[1] Liquid filled formulations were prepared by employing different cosolvents and surfactants. The formulation containing SLS-2%, PVP- 17.5%, PEG-15%, and PG-53% exhibited desire solubility, rheological property and found to be stable in hard gelatin capsules.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Deepthi, Y., & Murthy, T. E. G. (2015). Design and development and evaluation of candesartan cilexetil liquid filling formulations. International Journal of Pharmaceutical Investigation, 5(2), 81-86. https://doi.org/10.4103/2230-973X.153382

    Copyright and licence

    © 2015 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0